Related Experiment Videos
Immunotherapy of renal cell carcinoma
G P Haas1, G G Hillman, B G Redman
1Department of Urology, Wayne State University School of Medicine, Detroit, Michigan.
CA: a Cancer Journal for Clinicians
|May 1, 1993
Abstract:
Immunologic approaches to the therapy of metastatic renal cell carcinoma have provided moderate improvement in response rates for a disease that is extremely resistant to all forms of treatment. This article reviews recent clinical efforts using immunotherapy for renal cell carcinoma, including the adoptive transfer of cytotoxic killer cells and/or the use of biologic response modifiers, such as interferon and interleukin-2.